Litigation Details for Heron Therapeutics, Inc. v. Fresenius Kabi USA, LLC (D. Del. 2022)
✉ Email this page to a colleague
Heron Therapeutics, Inc. v. Fresenius Kabi USA, LLC (D. Del. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-07-27 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Patents | 10,500,208; 9,561,229; 9,808,465; 9,974,794 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Heron Therapeutics, Inc. v. Fresenius Kabi USA, LLC
Details for Heron Therapeutics, Inc. v. Fresenius Kabi USA, LLC (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-03-08 | 97 | Stipulation | alia, U.S. Patent Nos. 9,808,465 (“the ’465 patent”); 9,973,793 (“the ’793 patent”); 10,500,208 (“the ’208…respect to patents other than the ’465 patent, the ’793 patent, the ’208 patent, and the ’018 patent, and …invalidity of the ’465 patent, the ’793 patent, the ’208 patent, and the ’018 patent; and the parties have…claims of the ’465 patent, the ’793 patent, the ’208 patent, and the ’018 patent under 35 U.S.C. § 271… claims of the ’465 patent, the ’793 patent, the ’208 patent, and the ’018 patent. 3. All | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |